EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



NMR in Biomedicine

Description
an international journal devoted to the development and application of magnetic resonance in vivo

 

Status
active
Indexing
BIOBASE: Current Awareness in Biological Sciences (Elsevier)
Biochemistry & Biophysics Citation Index (Clarivate Analytics)
Biological Science Database (ProQuest)
CAS: Chemical Abstracts Service (ACS)
Chemical Abstracts Service/SciFinder (ACS)
ChemWeb (ChemIndustry.com)
COMPENDEX (Elsevier)
Current Contents: Life Sciences (Clarivate Analytics)
Embase (Elsevier)
INSPEC (IET)
Journal Citation Reports/Science Edition (Clarivate Analytics)
MEDLINE/PubMed (NLM)
Natural Science Collection (ProQuest)
Science Citation Index (Clarivate Analytics)
Science Citation Index Expanded (Clarivate Analytics)
SciTech Premium Collection (ProQuest)
SCOPUS (Elsevier)
SIIC Databases (Sociedad Iberoamericana de Informacion Cientifica)
Web of Science (Clarivate Analytics)
Subject

Source type
Journal
Publisher
ISBN ISSN
0952-3480
E ISSN
1099-1492
First volume
1
Last volume
33+
Publish city
London
Homepage
Description
NMR in Biomedicine is a journal devoted to the publication of original full-length papers, rapid communications and review articles describing the development of magnetic resonance spectroscopy or imaging methods or their use to investigate physiological, biochemical, biophysical or medical problems. Topics for submitted papers should be in one of the following general categories: (a) development of methods and instrumentation for MR of biological systems; (b) studies of normal or diseased organs, tissues, cells or body fluids; (c) diagnosis or treatment of disease. Reports may cover work on patients or healthy human subjects, in vivo animal experiments, studies of isolated organs or cultured cells, analysis of tissue extracts or body fluids, NMR theory, experimental techniques, or instrumentation. The Journal will not accept any papers that deal solely with the routine application of established MR imaging and post-processing methods in clinical studies. NMR in Biomedicine will accept for review manuscripts that focus on the use of MRI contrast agents in practical applications, but not those that are primarily concerned with the development, synthesis or ex vivo testing of contrast agents.











Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )